CURRENT OK-INBRE INVESTIGATORS

Tasquinimod and Nivolumab Combined Immunotherapy for Liver Cancer
Dr. Naushad Ali
University of Oklahoma Health Sciences Center

Regulation of C. difficile infection by the cytokine interleukin-22 (IL-22)
Dr. Lauren Zenewicz
University of Oklahoma Health Sciences Center

Developmental programming of mitochondrial biogenesis in maternal diabetes: Role of AMPK
Dr. Shaoning Jiang
University of Oklahoma Health Sciences Center

Role of Mcm10 in the maintenance of genome stability
Dr. Sapna Das-Bradoo
Northeastern State University

Mechanisms influencing expression of B7-H4, a target in cancer therapy
Dr. Christopher Horton
Southwestern Oklahoma State University

Development of small molecules targeting cancer metabolism
Dr. Horrick Sharma
Southwestern Oklahoma State University

Optical coherence vibrometry guided design of computational cochlear mechanics models
Dr. Scott Mattison
University of Central Oklahoma